Insider trade

Guardian Pharmacy Services (GRDN): Director sold ~$1.01M

John Ackerman, Director at Guardian Pharmacy Services, sold ~$1.01M of Guardian Pharmacy Services shares.

~$1.01M
Approx. value · 50K sh @ $20.16
150K
Holds after · shares reported
Traded
May 28, 2025
Filed
May 29, 2025

What stands out in this filing

  • The sale was 25.1% of the shares this insider held before it; the filing reports 149,794 shares, held indirectly afterwards.
  • 50,305 shares at an average of $20.16 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 27, 2025Insider · 7 peopleInsiders: 8 sales (~$263.6M)
  2. May 28, 2025 · this disclosureInsiderDirector sold ~$1.01M of GRDN shares in the open market

What came next

  1. May 28, 2025Insider · 7 peopleInsiders: 7 sales (~$47.9M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Guardian Pharmacy Services

For Guardian Pharmacy Services, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GRDN page.

Other recent filings by John Ackerman, Director

The full history of John Ackerman, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which Guardian Pharmacy Services (GRDN) insider traded, and how much?

John Ackerman, Director at Guardian Pharmacy Services, sold ~$1.01M of Guardian Pharmacy Services shares. 50K shares at $20.16.

When did it happen, and when was it made public?

Traded: May 28, 2025. Filed: May 29, 2025. That is 1 day between the two dates.

What stands out in this filing?

The sale was 25.1% of the shares this insider held before it; the filing reports 149,794 shares, held indirectly afterwards. 50,305 shares at an average of $20.16 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Guardian Pharmacy Services recently?

For Guardian Pharmacy Services, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the GRDN page.

Does this mean GRDN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Guardian Pharmacy Services

Everything OQRO holds on this company is on its GRDN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data